Table 4 Effect of surgical treatments of urge urinary incontinence on sexual function
From: Impact of urinary incontinence on female sexual health in women during midlife
Author | Study Design | N | Treatment | Instrument | Findings |
|---|---|---|---|---|---|
Obotulinumtoxin A injection | |||||
Nitti et al [77] | RCT | 1. Placebo: 243 | 1. Placebo | KHQ (Personal Relationship Domain) | • Clinically significant improvement in all KHQ scores, including Personal Relationship (-13.4 v -1.1, p < 0.001) |
2. Botox: 249 | 2. Botox 100 U follow up: 12 weeks | ||||
Sacral neuromodulation | |||||
Zahibi et al [78] | Prospective case series | 36 | SNM follow up: 6 months | FSFI | • Significant ↑ FSFI total and all subscale scores except desire |
• Pts with voiding dysfunction only: 157 % improvement in total FSFI | |||||
Signorello et al [79] | Prospective case series | 30 | SNM follow up: median 36.3 months | FSFI | • Significant improvement in total FSFI and most domains except orgasm |
• 25 % showed >50 % improvement on total FSFI | |||||
Gill et al [80] | Prospective case series | 8 | SNM follow up: median 3.2 months | FSFI, Female Sexual Health Questionnaire | • Significant improvement in arousal, satisfaction, orgasm |
• 50 % ↓ CI, restriction of SA due to UI | |||||
Pauls et al [81] | Prospective case series | 7 | SNM | FSFI | • Significant ↑ frequency, improvement of FSFI total and desire, lubrication, satisfaction, pain scores |
Ingber et al [82] | Prospective case series | 27 | SNM follow up: 6 months | FSFI | • Non-significant improvement in FSFI in OAB patients (18.6 → 22.4, p = 0.257) |